Literature DB >> 22112111

High-resolution imaging diagnosis of human fetal membrane by three-dimensional optical coherence tomography.

Hugang Ren1, Cecilia Avila, Cynthia Kaplan, Yingtian Pan.   

Abstract

Microscopic chorionic pseudocyst (MCP) arising in the chorion leave of the human fetal membrane (FM) is a clinical precursor for preeclampsia which may progress to fatal medical conditions (e.g., abortion) if left untreated. To examine the utility of three-dimensional (3D) optical coherence tomography (OCT) for noninvasive delineation of the morphology of human fetal membranes and early clinical detection of MCP, 60 human FM specimens were acquired from 10 different subjects undergoing term cesarean delivery for an ex vivo feasibility study. Our results showed that OCT was able to identify the four-layer architectures of human FMs consisting of high-scattering decidua vera (DV, average thickness d(DV) ≈ 92±38 μm), low-scattering chorion and trophoblast (CT, d(CT) ≈ 150±67 μm), high-scattering subepithelial amnion (A, d(A) ≈ 95±36 μm), and low-scattering epithelium (E, d(E) ≈ 29±8 μm). Importantly, 3D OCT was able to instantaneously detect MCPs (low scattering due to edema, fluid buildup, vasodilatation) and track (staging) their thicknesses d(MCP) ranging from 24 to 615 μm. It was also shown that high-frequency ultrasound was able to compliment OCT for detecting more advanced thicker MCPs (e.g., d(MCP)>615 μm) because of its increased imaging depth.

Entities:  

Mesh:

Year:  2011        PMID: 22112111      PMCID: PMC3221713          DOI: 10.1117/1.3646530

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  12 in total

1.  Enhancing detection of bladder carcinoma in situ by 3-dimensional optical coherence tomography.

Authors:  Hugang Ren; Zhijia Yuan; Wayne Waltzer; Kenneth Shroyer; Yingtian Pan
Journal:  J Urol       Date:  2010-08-17       Impact factor: 7.450

2.  A digital frequency ramping method for enhancing Doppler flow imaging in Fourier-domain optical coherence tomography.

Authors:  Zhijia Yuan; Z C Luo; H G Ren; C W Du; Yingtian Pan
Journal:  Opt Express       Date:  2009-03-02       Impact factor: 3.894

3.  Diagnosis of bladder cancer with microelectromechanical systems-based cystoscopic optical coherence tomography.

Authors:  Hugang Ren; Wayne C Waltzer; Rahuldev Bhalla; Jingxuan Liu; Zhijia Yuan; Christopher S D Lee; Frank Darras; David Schulsinger; Howard L Adler; Jason Kim; Alek Mishail; Yingtian Pan
Journal:  Urology       Date:  2009-08-05       Impact factor: 2.649

Review 4.  Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications.

Authors:  R B Ness; J M Roberts
Journal:  Am J Obstet Gynecol       Date:  1996-11       Impact factor: 8.661

Review 5.  Pre-eclampsia.

Authors:  Baha Sibai; Gus Dekker; Michael Kupferminc
Journal:  Lancet       Date:  2005 Feb 26-Mar 4       Impact factor: 79.321

Review 6.  Diagnosis and management of gestational hypertension and preeclampsia.

Authors:  Baha M Sibai
Journal:  Obstet Gynecol       Date:  2003-07       Impact factor: 7.661

7.  On the possibility of time-lapse ultrahigh-resolution optical coherence tomography for bladder cancer grading.

Authors:  Zhijia Yuan; Bai Chen; Hugang Ren; Yingtian Pan
Journal:  J Biomed Opt       Date:  2009 Sep-Oct       Impact factor: 3.170

8.  Microscopic chorionic pseudocysts in placental membranes: a histologic lesion of in utero hypoxia.

Authors:  Jerzy Stanek; Eric Weng
Journal:  Pediatr Dev Pathol       Date:  2007 May-Jun

9.  Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy.

Authors:  L Weinstein
Journal:  Am J Obstet Gynecol       Date:  1982-01-15       Impact factor: 8.661

10.  Three-dimensional endomicroscopy of the human colon using optical coherence tomography.

Authors:  Desmond C Adler; Chao Zhou; Tsung-Han Tsai; Joe Schmitt; Qin Huang; Hiroshi Mashimo; James G Fujimoto
Journal:  Opt Express       Date:  2009-01-19       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.